SK Capital Partners has completed the sale of IBA Molecular to CapVest Partners LP. Financial terms weren’t announced. IBA Molecular was jointly owned by SK Capital and Ion Beam Applications S.A. prior to the sale. Rothschild Inc served as exclusive financial advisor and Morgan, Lewis & Bockius LLP served as legal counsel to SK Capital.
March 23, 2016 08:00 AM Eastern Daylight Time
PARIS–(BUSINESS WIRE)–SK Capital Partners (“SK Capital”), a private investment firm focused on the specialty materials, chemicals and healthcare sectors, announced today the completion of the previously announced sale of IBA Molecular (“IBAM” or the “Company”) to funds advised by CapVest Partners LP (“CapVest”), an established European mid-market private equity firm. IBA Molecular was jointly owned by SK Capital and Ion Beam Applications S.A. prior to the sale. Terms of the transaction were not disclosed.
Since SK Capital acquired 60% of IBA Molecular in April 2012, the Company has successfully executed on a number of operational improvement initiatives and strategic transactions. Jamshid Keynejad, Founding Partner of SK Capital, said, “The Company’s leading position in its core markets provided a solid foundation for growth, while the efforts of Renaud Dehareng and his team, alongside support from SK Capital, helped drive the Company’s exceptional performance. We congratulate the IBA Molecular team on their accomplishments and wish the team and their new owners every success in the future.”
Rothschild Inc. served as exclusive financial advisor and Morgan, Lewis & Bockius LLP served as legal counsel to SK Capital for the transaction.
About SK Capital
SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors. The firm’s purpose is to build strong and growing businesses that create substantial long-term economic value. SK utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk.
SK Capital’s portfolio of businesses employs more than 9,000 people globally and operates more than 100 plants in 32 countries. SK Capital currently manages more than $1.5 billion of committed capital.
For more information, please visit www.skcapitalpartners.com
CapVest is an established European mid-market private equity firm focused on acquiring market leading companies supplying essential products and services. The firm places an emphasis on driving business growth through active management and has demonstrated consistent success in creating long-term value.